EVRIMA PLC
Evrima is, an investment issuer listed on the AQSE Growth Market. The company has an investment strategy focused on the identification of opportunities in the mining and exploration industry. The company is engaged in identifying opportunities that can deliver growth on a direct basis through active investment positions or indirectly through existing opportunities that may require capital, respective skills, or a combination of both to support growth. Evrima, will look to creatively enter and structure investment opportunities where the underlying commodity and the asset are aligned in its growth profile.
EVRIMA PLC
Industry:
Mining Venture Capital
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.evrimaplc.com
Total Employee:
1+
Status:
Active
Contact:
+44 (0) 20 377 81516
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Official Site Inspections
http://www.evrimaplc.com Semrush global rank: 4.53 M Semrush visits lastest month: 2.33 K
- Host name: 112.18.214.35.bc.googleusercontent.com
- IP address: 35.214.18.112
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043

More informations about "Evrima Plc"
Evrima PLC | Investment Issuer listed on the AQSE
Evrima is, an investment issuer listed on the AQSE Growth Market. The company has an investment strategy focused on the identification of opportunities in the mining and exploration โฆSee details»
Strategic Report, Report of the Directors and - evrimaplc.com
Evrima PLC (Registered number: 06474216) Strategic Report for the year ended 31 December 2022 17 August 2022 - First assay results released from the 2022 diamond drill program โฆSee details»
Evrima Plc - Crunchbase Company Profile & Funding
Organization. Evrima Plc . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. Evrima company has an investment strategy focused on the โฆSee details»
Strategic Report, Report of the Directors and - Evrima PLC
-4- Evrima PLC (Registered number: 06474216) Strategic Report for the year ended 31 December 2023 Phudulooga, meanwhile, is a shear hosted high-grade hydrothermal deposit โฆSee details»
Evrima (AQU:EVA) Company Profile & Description - Stock Analysis
Mar 14, 2025 Company profile for Evrima PLC (AQU:EVA) with a description, list of executives, contact details and other key facts.See details»
Evrima PLC (EVA.AQ) Company Profile & Facts - Yahoo Finance
See the company profile for Evrima PLC (EVA.AQ) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives โฆSee details»
Evrima PLC, 79R:FRA profile - FT.com - Financial Times
Mar 21, 2025 Evrima PLC (79R:FRA) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.See details»
Evrima PLC: Shareholders Board Members Managers and โฆ
Evrima PLC: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Deutsche Boerse AG: | Deutsche ...See details»
Evrima Company Profile - Office Locations, Competitors, Revenue โฆ
Oct 29, 2024 See insights on Evrima including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Evrima Plc (EVA) - Aquis Stock Exchange
Mar 21, 2025 Evrima Plc (EVA) Company Page. View share price, share charts, recent trades, company information, news, financial results, research and moreSee details»
EVRIMA PLC Company Profile | LONDON, United Kingdom - Dun โฆ
Find company research, competitor information, contact details & financial data for EVRIMA PLC of LONDON. Get the latest business insights from Dun & Bradstreet.See details»
Evrima - Overview, News & Competitors | ZoomInfo.com
View Evrima (www.evrimaplc.com) location in Greater London, United Kingdom , revenue, industry and description. Find related and similar companies as well as employees by title and โฆSee details»
Evrima
Karla Dorsch is the Founder and Managing Director of Evrima. She has a broad level of expertise achieved over 25 years of experience in executive search. Ms. Dorsch and her team have โฆSee details»
Evrima PLC (EVA.AQ) company profile and facts - Yahoo Finance
See the company profile for Evrima PLC (EVA.AQ), including business summary, industry/sector information, number of employees, corporate governance, key executives and salary information.See details»
Discover Evrima. We enable and expedite the clinical trial process.
Our clinical trial recruitment and management services put participants first. Trusted, timely clinical trial results are a good thing - for everybody.See details»
Evrima Company Profile: Funding, Investors & Partnerships
Our mission is to accelerate patient identification and recruitment to help advance medical development. Weโre driven to reduce the administrative burden on researchers so they can โฆSee details»
Full Year Results 2021 - Evrima PLC
We are using cookies to give you the best experience on our website. You can find out more about which cookies we are using or switch them off in settings.See details»
Evrima 2025 Company Profile: Valuation, Funding & Investors
Evrima General Information Description. Operator of a clinical trial technology platform intended to streamline participant recruitment and trial management. The company platform offers โฆSee details»
Discover better clinical trial recruitment and management services
Patient-centred, tech-empowered. Weโre reimagining clinical trials around the world. Now. We exist to help make medical research breakthroughs happen by expediting and enabling a โฆSee details»
Bridging the gap: the story behind our rebrand - evrima.com
Sep 28, 2023 Overview. From the very beginning, our vision has been to help make medical research breakthroughs happen by expediting and enabling a better clinical trial process - for โฆSee details»